跳至主要内容
临床试验/NCT01862237
NCT01862237Unknown不适用

Does Type II Diabetes Influence Prognosis and Left Ventricular Remodeling in Patients With Aortic Valve Stenosis Referred for Aortic Valve Replacement ?

Hospices Civils de Lyon1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2012年12月最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
1
主要终点
Left Ventricular Mass measured by echocardiography

研究概览

简要总结

This project focuses on the physiopathology of left ventricular remodeling associated with type II diabetes in patients with aortic valve stenosis referred for surgical aortic valve replacement.

The main objective is to compare the reverse left ventricular remodeling between patients with type II diabetes and case-control patients without diabetes at one(1) year after surgical aortic valve replacement.

The secondary objectives are :

  1. assess the influence of type II diabetes on left ventricular remodeling in patients presenting with aortic valve stenosis,
  2. assess the predictive value of myocardial fibrosis and other LV characteristics present prior to aortic valve surgery on the LV reverse remodeling and their influence on cardiovascular events at one (1) year after surgery,
  3. assess the influence of type II diabetes on cardiovascular morbidity and mortality post aortic valve surgery.

The investigators main hypothesis is that patients with type II diabetes and aortic valve stenosis requiring aortic valve replacement have poorer LV function and less favorable post surgery clinical outcomes than patients without type II diabetes.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years
  • Arm 1: Treated Type II diabetes, Arm 2: absence of type II diabetes
  • Aortic valve stenosis
  • LVEF > 50% with no kinetic abnormalities
  • Non significant obstructive coronary artery disease
  • Absence of gadolinium enhanced MRI contraindications
  • Informed consent signed
  • Patient affiliated to the French Social Security.

排除标准

  • Chronic arrhythmia or absence of sinus rhythm
  • Past history of cardiomyopathy or coronary insufficiency
  • Significant coronaropathy seen during the coronary angiography with >50% degree stenosis prior to aortic valve replacement
  • Hemodynamically significant valvular dysfunction other than aortic stenosis (grade 2 mitral or aortic insufficiency, mitral valve stenosis < 1.5 cm2)
  • Systemic chronic inflammatory disease leading to cardiac injury (scleroderma)
  • Renal insufficiency (clearance < 30 ml/min)
  • Insufficient transthoracic echocardiography echogenicity
  • Type I diabetes mellitus
  • Uncontrolled hypertension (> 180/100 mm Hg)

结局指标

主要结局

Left Ventricular Mass measured by echocardiography

时间窗: Primary outcome is assessed at one year 1 year after aortic valve replacement.

次要结局

  • Magnetic Resonance Imaging (MRI) parameters.(1 year after aortic valve replacement.)
  • Measurement of BNP (Brain Natriuretic Peptide).(1 year after aortic valve replacement.)
  • Echocardiographic parameters.(1 year after aortic valve replacement.)
  • cardiovascular events (cardiac mortality, heart failure, atrial or ventricular rhythm abnormalities) and clinical improvement (NYHA class, 6-minute walk test).(1 year after aortic valve replacement.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验